相关实验视频

Updated: Jul 21, 2025

Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay
08:13

Evaluation of Zebrafish Kidney Function Using a Fluorescent Clearance Assay

Published on: February 20, 2015

13.3K

布罗苏马布在X结合的低酸血症中的有效性和安全性

Sen Wang1, Xiaoqin Wang1, Miao He2

  • 1Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.

The Journal of clinical endocrinology and metabolism
|July 27, 2023
PubMed
概括

布罗苏马布有效地通过增加和维生素D水平来治疗X相关的低血症 (XLH). 这一系统性审查发现,布罗苏马布是XLH患者的安全治疗选择,严重不良事件的发生率很低.

关键词:
与X相关的低酸血症.不良事件是不良事件.这就是Burosumab.纤维细胞生长因子 23 23这是一个元分析.这是一种单克隆抗体.血清的含量 血清的

更多相关视频

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease10:16

In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease

Published on: December 20, 2017

8.1K
Disruption of the Blood-Spinal Cord Barrier Using Low-Intensity Focused Ultrasound in a Rat Model09:03

Disruption of the Blood-Spinal Cord Barrier Using Low-Intensity Focused Ultrasound in a Rat Model

Published on: March 10, 2023

2.0K

相关概念视频

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
206